Synthetic Cannabinoids—Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis

  title={Synthetic Cannabinoids—Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis},
  author={L. Fattore},
  journal={Biological Psychiatry},
  • L. Fattore
  • Published 2016
  • Medicine
  • Biological Psychiatry
  • Consumption of synthetic mind-altering compounds, also known as "new psychoactive substances," is increasing globally at an alarming rate. Synthetic cannabinoids (SCs) are among the most commonly used new psychoactive substances. They are usually purchased as marijuana-like drugs, marketed as herbal blends and perceived as risk-free by inexperienced users. Yet, contrary to Δ(9)-tetrahydrocannabinol, SCs may lead to severe health consequences, including anxiety, tachycardia, hallucinations… CONTINUE READING
    97 Citations
    Synthetic Cannabinoid Use
    • 3
    Synthetic Cathinone and Cannabinoid Designer Drugs Pose a Major Risk for Public Health
    • 65
    • PDF
    Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis
    • 113
    • PDF
    Psychopathological symptoms associated with synthetic cannabinoid use: a comparison with natural cannabis
    • 11
    • PDF
    Synthetic and Non-synthetic Cannabinoid Drugs and Their Adverse Effects-A Review From Public Health Prospective
    • 35
    • Highly Influenced
    • PDF
    Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset.
    • 20
    • PDF
    The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic Review
    • 33
    • Highly Influenced
    • PDF
    Old and new synthetic cannabinoids: lessons from animal models
    • 9
    The Synthetic Cannabinoids Phenomenon.
    • 23


    Synthetic cannabinoid induced psychosis in a previously nonpsychotic patient.
    • 36
    • PDF
    Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
    • 209
    Novel psychoactive substances of interest for psychiatry
    • 154
    • PDF
    Beyond THC: The New Generation of Cannabinoid Designer Drugs
    • 313
    • PDF
    The Synthetic Cannabinoid Withdrawal Syndrome
    • 76